p100 increases AT1R expression through interaction with AT1R 3′-UTR

Nucleic Acids Research

Volumn 36, Issue 13, 2008, Pages 4474-4487

  Paukku, Kirsi ^a   Kalkkinen, Nisse ^b   Silvennoinen, Olli ^c,d   Kontula, Kimmo K ^a,e   Lehtonen, Jukka Y A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e NONE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ARGONAUTE 2 PROTEIN; MESSENGER RNA; NUCLEASE; NUCLEOTIDE; PROTEIN P100; RNA INDUCED SILENCING COMPLEX;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RNA STABILITY; RNA TRANSLATION;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL LINE; DOWN-REGULATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EUKARYOTIC INITIATION FACTOR-2; GENES, REPORTER; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICRORNAS; NUCLEAR PROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA STABILITY; RNA, MESSENGER; RNA-INDUCED SILENCING COMPLEX;

EID: 48349120496     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn411     Document Type: Article

References (57)

1. Zhang,T., Kruys,V., Huez,G. and Gueydan,C. (2002) AU-rich element-mediated translational control: Complexity and multiple activities of trans-activating factors. Biochem. Soc. Trans., 30, 952-958.
2. Audic,Y. and Hartley,R.S. (2004) Post-transcriptional regulation in cancer. Biol. Cell, 96, 479-498.
3. Wilusz,C.J. and Wilusz,J. (2004) Bringing the role of mRNA decay in the control of gene expression into focus. Trends Genet., 20, 491-497.
4. Olsen,P.H. and Ambros,V. (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol., 216, 671-680.
5. Seggerson,K., Tang,L. and Moss,E.G. (2002) Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev. Biol., 243, 215-225.
6. Zeng,Y., Wagner,E.J. and Cullen,B.R. (2002) Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell, 9, 1327-1333.
7. Doench,J.G., Petersen,C.P. and Sharp,P.A. (2003) siRNAs can function as miRNAs. Genes Dev., 17, 438-442.
8. Doench,J.G. and Sharp,P.A. (2004) Specificity of microRNA target selection in translational repression. Genes Dev., 18, 504-511.
9. Liu,J., Carmell,M.A., Rivas,F.V., Marsden,C.G., Thomson,J.M., Song,J.J., Hammond,S.M., Joshua-Tor,L. and Hannon,G.J. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science, 305, 1437-1441.
10. Meister,G., Landthaler,M., Patkaniowska,A., Dorsett,Y., Teng,G. and Tuschl,T. (2004) Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell, 15, 185-197.
11. Pillai,R.S., Artus,C.G. and Filipowicz,W. (2004) Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis. RNA, 10, 1518-1525.
12. Song,J.J., Smith,S.K., Hannon,G.J. and Joshua-Tor,L. (2004) Crystal structure of Argonaute and its implications for RISC slicer activity. Science, 305, 1434-1437.
13. de Gasparo,M., Catt,K.J., Inagami,T., Wright,J.W. and Unger,T. (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev., 52, 415-472.
14. Nickenig,G. and Murphy,T.J. (1994) Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression. Mol. Pharmacol., 46, 653-659.
15. Nickenig,G. and Murphy,T.J. (1996) Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol. Pharmacol., 50, 743-751.
16. Nickenig,G., Sachinidis,A., Michaelsen,F., Bohm,M., Seewald,S. and Vetter,H. (1997) Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation, 95, 473-478.
17. Nickenig,G., Baumer,A.T., Grohe,C., Kahlert,S., Strehlow,K., Rosenkranz,S., Stablein,A., Beckers,F., Smits,J.F., Daemen,M.J. et al. (1998) Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation, 97, 2197-2201.
18. Nickenig,G., Roling,J., Strehlow,K., Schnabel,P. and Bohm,M. (1998) Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation, 98, 2453-2460.
19. Nickenig,G. and Bohm,M. (1998) Interaction between insulin and AT1 receptor. Relevance for hypertension and arteriosclerosis. Basic Res. Cardiol., 93 (Suppl. 2), 135-139.
20. Nickenig,G., Michaelsen,F., Muller,C., Berger,A., Vogel,T., Sachinidis,A., Vetter,H. and Bohm,M. (2002) Destabilization of AT(1) receptor mRNA by calreticulin. Circ. Res., 90, 53-58.
21. Pende,A., Giacche,M., Castigliola,L., Contini,L., Passerone,G., Patrone,M., Port,J.D. and Lotti,G. (1999) Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA. Biochem. Biophys. Res. Commun., 266, 609-614.
22. Martin,M.M., Lee,E.J., Buckenberger,J.A., Schmittgen,T.D. and Elton,T.S. (2006) MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem., 281, 18277-18284.
23. Callebaut,I. and Mornon,J.P. (1997) The human EBNA-2 coactivator p100: multidomain organization and relationship to the staphylococcal nuclease fold and to the tudor protein involved in Drosophila melanogaster development. Biochem. J., 321(Pt 1), 125-132.
24. Caudy,A.A., Ketting,R.F., Hammond,S.M., Denli,A.M., Bathoorn,A.M., Tops,B.B., Silva,J.M., Myers,M.M., Hannon,G.J. and Plasterk,R.H. (2003) A micrococcal nuclease homologue in RNAi effector complexes. Nature 425, 411-414.
25. Valineva,T., Yang,J., Palovuori,R. and Silvennoinen,O. (2005) The transcriptional co-activator protein p100 recruits histone acetyl-transferase activity to STAT6 and mediates interaction between the CREB-binding protein and STAT6. J. Biol. Chem., 280, 14989-14996.
26. Selenko,P., Sprangers,R., Stier,G., Buhler,D., Fischer,U. and Sattler,M. (2001) SMN tudor domain structure and its interaction with the Sm proteins. Nat. Struct. Biol., 8, 27-31.
27. Battle,D.J., Kasim,M., Yong,J., Lotti,F., Lau,C.K., Mouaikel,J., Zhang,Z., Han,K., Wan,L. and Dreyfuss,G. (2006) The SMN complex: An assembly machine for RNPs. Cold Spring Harb. Symp. Quant. Biol., 71, 313-320.
28. Tong,X., Drapkin,R., Yalamanchili,R., Mosialos,G. and Kieff,E. (1995) The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol., 15, 4735-4744.
29. Schwarz,D.S., Tomari,Y. and Zamore,P.D. (2004) The RNA-induced silencing complex is a Mg2+-dependent endonuclease. Curr. Biol., 14, 787-791.
30. Grifoni,S.C., Gannon,K.P., Stec,D.E. and Drummond,H.A. (2006) ENaC proteins contribute to VSMC migration. Am. J. Physiol. Heart Circ. Physiol., 291, H3076-3086.
31. Yang,J., Aittomaki,S., Pesu,M., Carter,K., Saarinen,J., Kalkkinen,N., Kieff,E. and Silvennoinen,O. (2002) Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. Embo J., 21, 4950-4958.
32. Masuda,H., Fukabori,Y., Nakano,K., Shimizu,N. and Yamanaka,H. (2004) Expression of bone morphogenetic protein-7 (BMP-7) in human prostate. Prostate, 59, 101-106.
33. Minami,M., Dainion,Y., Mori,K., Takashima,H., Nakajima,T., Itoh,Y. and Okanoue,T. (2005) Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis. Oncogene, 24, 4340-4348.
34. Shevchenko,A., Wilm,M., Vorm,O. and Mann,M. (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem., 68, 850-858.
35. Peritz,T., Zeng,F., Kannanayakal,T.J., Kilk,K., Eiriksdottir,E., Langel,U. and Eberwine,J. (2006) Immunoprecipitation of mRNA-protein complexes. Nat. Protoc., 1, 577-580.
36. Akishita,M., Ito,M., Lehtonen,J.Y., Daviet,L., Dzau,V.J. and Horiuchi,M. (1999) Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J. Clin. Invest., 103, 63-71.
37. Li,C.L., Yang,W.Z., Chen,Y.P. and Yuan,H.S. (2008) Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing. Nucleic Acids Res., 36, 3579-3589.
38. Paukku,K., Yang,J. and Silvennoinen,O. (2003) Tudor and nuclease-like domains containing protein p100 function as coactivators for signal transducer and activator of transcription 5. Mol. Endocrinol., 17, 1805-1814.
39. Leverson,J.D., Koskinen,P.J., Orrico,F.C., Rainio,E.M., Jalkanen,K.J., Dash,A.B., Eisenman,R.N. and Ness,S.A. (1998) Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell, 2, 417-425.
40. Yang,J., Valineva,T., Hong,J., Bu,T., Yao,Z., Jensen,O.N., Frilander,M.J. and Silvennoinen,O. (2007) Transcriptional co-activator protein p100 interacts with snRNP proteins and facilitates the assembly of the spliceosome. Nucleic Acids Res., 35, 4485-4494.
41. O'Connell,M.A. and Keegan,L.P. (2006) Drosha versus ADAR: Wrangling over pri-miRNA. Nat. Struct. Mol. Biol., 13, 3-4.
42. Yang,W., Chendrimada,T.P., Wang,Q., Higuchi,M., Seeburg,P.H., Shiekhattar,R. and Nishikura,K. (2006) Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol., 13, 13-21.
43. Scadden,A.D. (2005) The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat. Struct. Mol. Biol., 12, 489-496.
44. Agrawal,N., Dasaradhi,P.V., Mohmmed,A., Malhotra,P., Bhatnagar,R.K. and Mukherjee,S.K. (2003) RNA interference: Biology, mechanism, and applications. Microbiol. Mol. Biol. Rev., 67, 657-685.
45. Maniataki,E. and Mourelatos,Z. (2005) A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes Dev., 19, 2979-2990.
46. Caudy,A.A., Myers,M., Hannon,G.J. and Hammond,S.M. (2002) Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev., 16, 2491-2496.
47. Ikeda,K., Satoh,M., Pauley,K.M., Fritzler,M.J., Reeves,W.H. and Chan,E.K. (2006) Detection of the argonaute protein Ago2 and microRNAs in the RNA induced silencing complex (RISC) using a monoclonal antibody. J. Immunol. Methods, 317, 38-44.
48. Tsuchiya,N., Ochiai,M., Nakashima,K., Ubagai,T., Sugimura,T. and Nakagama,H. (2007) SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res., 67, 9568-9576.
49. Keenan,T.W., Winter,S., Rackwitz,H.R. and Heid,H.W. (2000) Nuclear coactivator protein p100 is present in endoplasmic reticulum and lipid droplets of milk secreting cells. Biochim. Biophys. Acta, 1523 84-90.
50. Porta,A., Colonna-Romano,S., Callebaut,I., Franco,A., Marzullo,L., Kobayashi,G.S. and Maresca,B. (1999) An homologue of the human 100-kDa protein (p100) is differentially expressed by Histoplasma capsulatum during infection of murine macrophages. Biochem. Biophys. Res. Commun., 254, 605-613.
51. Palacios,L., Ochoa,B., Gomez-Lechon,M.J., Castell,J.V. and Fresnedo,O. (2006) Overexpression of SND p102, a rat homologue of p100 coactivator, promotes the secretion of lipoprotein phospholipids in primary hepatocytes. Biochim. Biophys. Acta, 1761, 698-708.
52. Broadhurst,M.K. and Wheeler,T.T. (2001) The p100 coactivator is present in the nuclei of mammary epithelial cells and its abundance is increased in response to prolactin in culture and in mammary tissue during lactation. J. Endocrinol., 171, 329-337.
53. Sakamoto,K., Yamasaki,Y., Kaneto,H., Fujitani,Y., Matsuoka,T., Yoshioka,R., Tagawa,T., Matsuhisa,M., Kajimoto,Y. and Hori,M. (1999) Identification of oxidative stress-regulated genes in rat aortic smooth muscle cells by suppression subtractive hybridization. FEBS Lett., 461, 47-51.
54. Antic,D. and Keene,J.D. (1997) Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am. J. Hum. Genet., 61, 273-278.
55. Brennan,C.M. and Steitz,J.A. (2001) HuR and mRNA stability. Cell. Mol. Life Sci., 58, 266-277.
56. Fan,X.C. and Steitz,J.A. (1998) HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl Acad. Sci. USA, 95, 15293-15298.
57. Ji,X., Kong,J., Carstens,R.P. and Liebhaber,S.A. (2007) The 3′ untranslated region complex involved in stabilization of human alpha-globin mRNA assembles in the nucleus and serves an independent role as a splice enhancer. Mol. Cell. Biol., 27, 3290-3302.